These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32972438)

  • 1. Advances in the assessment of minimal residual disease in mantle cell lymphoma.
    Jung D; Jain P; Yao Y; Wang M
    J Hematol Oncol; 2020 Sep; 13(1):127. PubMed ID: 32972438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
    Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of mantle cell lymphoma.
    Jares P; Colomer D; Campo E
    J Clin Invest; 2012 Oct; 122(10):3416-23. PubMed ID: 23023712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma.
    Lokvenc M; Kalinova M; Forsterova K; Klener P; Trneny M; Fronkova E; Kodet R
    Ann Hematol; 2018 Mar; 97(3):467-474. PubMed ID: 29273915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pitfalls and update in haematopathology. Case 2. "Early phase" mantle cell lymphoma of the lymph node].
    Copie-Bergman C
    Ann Pathol; 2012 Oct; 32(5):336-40. PubMed ID: 23141941
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma.
    Wu S; Blombery P; Westerman D; Tam CS
    Curr Treat Options Oncol; 2023 Aug; 24(8):929-947. PubMed ID: 37249800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.
    Szostakowska M; Szymczyk M; Badowska K; Tudek B; Fabisiewicz A
    Med Oncol; 2018 Mar; 35(4):49. PubMed ID: 29520657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?
    Simonsen AT; Schou M; Sørensen CD; Bentzen HH; Nyvold CG
    Leuk Lymphoma; 2015; 56(9):2724-7. PubMed ID: 25629991
    [No Abstract]   [Full Text] [Related]  

  • 12. VH gene repertoire of mantle cell lymphomas.
    Varade W; Marin E; Milano M; Insel R; Swerdlow S; Williams M
    Ann N Y Acad Sci; 1995 Sep; 764():504-6. PubMed ID: 7486576
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
    Scapinello G; Riva M; Branca A; Pizzi M; Bonaldi L; Martines A; Manni S; Visentin A; Trentin L; Semenzato G; Gurrieri C; Piazza F
    Ann Hematol; 2020 Nov; 99(11):2715-2717. PubMed ID: 32671454
    [No Abstract]   [Full Text] [Related]  

  • 14. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
    Nodit L; Bahler DW; Jacobs SA; Locker J; Swerdlow SH
    Hum Pathol; 2003 Oct; 34(10):1030-4. PubMed ID: 14608537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
    Witzig TE
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):825-835. PubMed ID: 32861280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.
    Genuardi E; Romano G; Beccuti M; Alessandria B; Mannina D; Califano C; Rota Scalabrini D; Cortelazzo S; Ladetto M; Ferrero S; Calogero RA; Cordero F
    Br J Haematol; 2021 Jul; 194(2):378-381. PubMed ID: 34002365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.
    Yamaguchi M; Ohno T; Miyata E; Toyoda H; Nishii K; Masuya M; Kita K; Shiku H
    Int J Hematol; 2001 Apr; 73(3):383-5. PubMed ID: 11345207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease monitoring by 8-color flow cytometry in mantle cell lymphoma: an EU-MCL and LYSA study.
    Cheminant M; Derrieux C; Touzart A; Schmit S; Grenier A; Trinquand A; Delfau-Larue MH; Lhermitte L; Thieblemont C; Ribrag V; Cheze S; Sanhes L; Jardin F; Lefrère F; Delarue R; Hoster E; Dreyling M; Asnafi V; Hermine O; Macintyre E
    Haematologica; 2016 Mar; 101(3):336-45. PubMed ID: 26703963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.